Sophont says Holon-S1 maps predicted gene activity from routine slides
Co-founder Tanishq Mathew Abraham says Holon-S1 can help researchers study archived cancer slides. The model is for research use only, and its clinical utility still needs testing.
By RuntimeWire Staff · Published
Primary source: PR Newswire
Why it matters
Holon-S1 tests whether AI can turn widely available pathology slides into useful biological hypotheses. Its research-only status and company-reported results leave independent reproducibility and clinical utility unproven.
Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) built his career around applying AI to pathology. On October 20th, the Sophont co-founder introduced Holon-S1, a research model that predicts where genes and biological pathways are active in tumors using routine H&E pathology slides.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.